Compare SNAL & DAVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SNAL | DAVI |
|---|---|---|
| Founded | 2000 | 2022 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 21.2M | 25.0M |
| IPO Year | 2022 | 2025 |
| Metric | SNAL | DAVI |
|---|---|---|
| Price | $2.34 | $0.93 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 150.0K | ★ 369.2K |
| Earning Date | 11-12-2026 | 04-06-2027 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 120.00 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $81,225,622.00 | N/A |
| Revenue This Year | $25.62 | N/A |
| Revenue Next Year | $7.81 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.59 | $0.91 |
| 52 Week High | $21.60 | $6.05 |
| Indicator | SNAL | DAVI |
|---|---|---|
| Relative Strength Index (RSI) | 52.03 | 14.26 |
| Support Level | $1.92 | $0.91 |
| Resistance Level | $2.63 | $1.18 |
| Average True Range (ATR) | 0.31 | 0.23 |
| MACD | 0.03 | 0.06 |
| Stochastic Oscillator | 46.55 | 7.60 |
Snail Inc is an independent developer and publisher of interactive digital entertainment for consumers around the world, with a portfolio of premium games designed for use on a variety of platforms, including consoles, PC's, and mobile devices. The geographic presence of the company is in the United States and the International market, where the majority of its revenue comes from the United States. The Company has one operating and reportable segment. The company operates in the USA, the UK and Other Countries.
Davion Healthcare PLC is focus on developing its range of home tests for a range of home test products, to identify potential medical conditions and provide early warning to enable further clinical examination where applicable. It designs, develops, and patents medical products and non-diagnostic devices and then licenses the manufacturing, marketing, sales, and distribution rights for its products to regional or world-wide commercial partners. The company has been operating as a single segment. Its products are BreastCheck, FootFlow, and Testic.